and over-weight subjects who responded and met
entry criteria during a telephone screening interview were scheduled for a baseline visit. The evaluation included a physical examination, electrocardiogram, and screening blood studies. Subjects meeting entry criteria were seen within 2 weeks for randomization at
treatment week 0. Subjects were assigned to placebo or active compound
with equal probability through a random number generator.